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Background: The relationship between diet and survival after ovarian cancer diagnosis is unclear as a result of a limited number of
studies and inconsistent findings.
Methods:We examined the association between pre-diagnostic diet and overall survival in a population-based cohort (n¼ 811) of
Australian women diagnosed with invasive epithelial ovarian cancer between 2002 and 2005. Diet was measured by validated food
frequency questionnaire. Deaths were ascertained up to 31 August 2014 via medical record review and Australian National Death
Index linkage. We conducted Cox proportional hazards regression analysis, controlling for diagnosis age, tumour stage, grade
and subtype, residual disease, smoking status, body mass index, physical activity, marital status, and energy intake.
Results: We observed improved survival with highest compared with lowest quartile of fibre intake (hazard ratio (HR)¼ 0.69, 95%
CI: 0.53–0.90, P-trend¼ 0.002). There was a suggestion of better survival for women with highest compared with lowest intake
category of green leafy vegetables (HR¼ 0.79, 95% CI: 0.62–0.99), fish (HR¼ 0.74, 95% CI: 0.57–0.95), poly- to mono-unsaturated fat
ratio (HR¼ 0.76, 95% CI: 0.59–0.98), and worse survival with higher glycaemic index (HR¼ 1.28, 95% CI: 1.01–1.65, P-trend¼ 0.03).
Conclusions: The associations we observed between healthy components of diet pre-diagnosis and ovarian cancer survival raise
the possibility that dietary choices after diagnosis may improve survival.
Ovarian cancer has the highest mortality rate of all gynaecologic
cancers (Hunn and Rodriguez, 2012), with the majority of women
diagnosed at more advanced disease stages. Data from population-
based registries have demonstrated that survival rates have not
improved appreciably over time (Horner et al, 2009; Australian
Institute of Health and Welfare, 2014). Lack of early screening
tools and curative chemotherapy, as well as tumour molecular
heterogeneity, are challenges to controlling the burden of disease
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(Hunn and Rodriguez, 2012). Observations that women with the
same cancer characteristics given similar treatments can have
different outcomes suggest there may be factors in addition to non-
modifiable cancer characteristics that can influence survival
(Bandera et al, 2009; Thomson and Alberts, 2010). Efforts to
identify modifiable lifestyle factors that improve ovarian cancer
survival have consequently gained momentum.
The mechanisms that drive ovarian carcinogenesis are not fully
characterised, but may include elevated circulating gonadotropins,
sex-steroid hormones, inflammatory cytokines, and altered glucose
homeostasis (Ness and Modugno, 2006; Bandera et al, 2009; Wang
and Sun, 2009; Yang et al, 2012). While diet has been shown to
influence these mechanistic pathways and modify the carcinogenic
process for other cancers (van Kruijsdijk et al, 2009; George et al,
2010), only five relatively large (N¼ 244–636) observational
studies to our knowledge have explored the effects of diet on
survival after ovarian cancer diagnosis and findings have been
heterogeneous (Nagle et al, 2003; Zhang et al, 2004; Sakauchi et al,
2007; Dolecek et al, 2010; Thomson et al, 2014). Nonetheless,
limited data indicate that diet may be associated with survival
among women diagnosed with ovarian cancer, with some evidence
of possible benefit from greater fruit and vegetable intake (Nagle
et al, 2003; Dolecek et al, 2010), vitamin E (Nagle et al, 2003), green
tea (Zhang et al, 2004), and overall diet quality (Thomson et al,
2014).
We agnostically explored the associations between 34 dietary
exposures representing usual food, beverage, nutrient, and dietary
supplement intake before diagnosis and overall survival in 811
women with invasive ovarian cancer who participated in the
Australian Ovarian Cancer Study (AOCS), a nationwide case–
control study.
MATERIALS AND METHODS
Australian ovarian cancer study. The AOCS has previously been
described (Merritt et al, 2008). Briefly, women aged 18–79 years
with a diagnosis of invasive or borderline epithelial ovarian,
fallopian tube, or primary peritoneal cancer diagnosed between
January 2002 and June 2006 were enrolled. The current analysis
excluded women with borderline disease. Women were identified
through gynaecologic oncology units and mandatory state-based
cancer registries. Ethics approval and informed consent were
obtained before enrolment. After exclusions (i.e., diagnosis not
primary epithelial ovarian cancer or before study initiation, not an
Australian resident), 1709 out of 2745 women agreed to
participate; 1612 (94%) returned the main study questionnaire.
Of these, 1132 women diagnosed with invasive disease before July
2005 also completed a food frequency questionnaire (FFQ).
Women recruited in the final year of the study (n¼ 242) were
not asked to complete the FFQ. After excluding participants who
omitted 14 (10%) or more FFQ line items, those with implausible
caloric intakes (o700 or 44000 kcal per day), and women who
reported changing their diet over the 6–12 months before diagnosis
because they were asked to report their diet before it changed
(n¼ 309), dietary data were available for 811 women with invasive
ovarian cancer.
Mortality ascertainment and follow-up. Vital status was deter-
mined through data abstracted from medical records every 6–12
months, and probabilistic record data linkage to the Australian
National Death Index at the Australian Institute of Health and
Welfare. All-cause mortality was the end point for follow-up,
however, of those with cause of death information (90%, n¼ 733),
95% of deaths were attributed to ovarian cancer. Participants were
followed for a mean of 5.9±3.8 years. Survival time was defined as
the interval between histologic diagnosis and date of death or
censored at 31 August 2014. Left-truncated survival analyses were
performed to account for the time elapsed between the date of
diagnosis and study recruitment, in order to eliminate survivorship
bias from excluding eligible women who died before study
recruitment.
Covariates. Clinical data including International Federation of
Obstetricians and Gynecologists stage (I/II and III/IV), tumour
grade (well, moderately, or poorly differentiated, and missing),
amount of residual tumour after surgery (none, p1 cm, 41 cm,
and missing), and histological subtype (serous, mucinous,
endometrioid, clear cell, and other) were collected from histology
reports and medical records. Socio-demographic and lifestyle
information including age at diagnosis, education (school only,
trade or technical qualification, and university), comorbid condi-
tions including diabetes (none and X1), smoking status (current,
former, and never), height and weight (used to calculate body mass
index (BMI): o18.5; 18.5–o25; 25–o30, and X30 kgm 2),
amount of physical activity (low, medium, and high physical
activity index (PAI)), and reproductive and hormonal data were
obtained via self-administered questionnaire at study enrolment.
Inclusion of a variable for the time elapsed between diagnosis and
dietary assessment did not alter the effect estimates of interest so
this was not included in the final models.
Dietary exposure assessment. Dietary intake was measured at
recruitment via a semi-quantitative, 135-item FFQ adapted from
that developed by Willett et al (1985, 1987; Ashton, 1996) and
validated in an Australian population (McNaughton et al, 2005;
Marks et al, 2006; Ibiebele et al, 2009). Questionnaires were
completed a median of 3.3 months after diagnosis and intake was
assessed for the year before diagnosis. Participants reported usual
frequency of intake over the previous 12 months for standard
serving sizes of food items and beverages. Frequency categories
included ‘o1’ or ‘1–3’ times per month; ‘1’, ‘2–4’, or ‘5–6’ times per
week; and ‘1’, ‘2–3’, or ‘4þ ’ times per day. Nutrient intake was
estimated based on the Australian Food Composition Tables (Food
Standards Australia New Zealand, 2010) and energy-adjusted using
the residual method (Willett et al, 1997). Participants also reported
type, quantity, and frequency of intake of dietary supplements.
Nutrient intake from supplements was calculated by multiplying
intake frequency by nutrient content given in the Australian
Register of Therapeutic Goods (Therapeutic Goods
Administration, 2013) following a process reported by Ashton
et al (1997). Food group variables were calculated by summing the
number of standard serving sizes consumed per day of relevant
items in that group (items listed in Supplementary Table S1). Food
group serving size categorisation was based on the distribution of
intakes in the study population. Vegetable intake excluded
potatoes. Dietary supplement use was categorised as either (1)
non-user and user; or (2) non-user, o50th percentile of intake
among users, and 450th percentile of intake among users, where
data were available. Glycaemic index (GI) and glycaemic load (GL)
were calculated using the Australian GI database (FoodWorks
2007, Xyris Software, Professional Edition, Highgate Hill, QLD,
Australia) supplemented by the International Tables of Glycaemic
Index and Glycaemic Load values (2008) (Atkinson et al, 2008).
Dietary GL was calculated by multiplying grams of carbohydrate
per food serving by the GI of that food.
Statistical analysis. Crude survival probabilities were estimated
using the Kaplan–Meier technique. Associations between dietary
factors and overall survival were estimated using Cox proportional
hazards regression; multivariate hazard ratios (HRs) and 95% CIs
were generated using SAS (SAS, version 9.3; SAS Institute, Cary,
NC, USA). The underlying time-metric was person-time (months)
of follow-up. A formal test for proportionality was conducted by
modelling the interaction between the natural logarithm of follow-
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up time and main dietary variables. Where the proportional
hazards assumption was violated, a lag analysis was also conducted
by stratifying the Cox proportional hazards models by different
periods of follow-up time selected by inspecting the crude survival
curves (Bellera et al, 2010). Effect estimates presented in tables are
from models without the time interaction term.
A missing category was created for categorical variables with a
large number of missing values. Variables associated with survival
at Po0.10 in univariate models were evaluated in multivariate
models. Stepwise backward selection was used to generate the most
parsimonious models, retaining variables that improved model fit
assessed by likelihood ratio test and remained statistically
significant at Po0.05. Variables that were dropped from the
model were added back in to multivariate models one at a time to
confirm lack of effect on the estimates for each dietary exposure.
The final multivariate models were adjusted for age at diagnosis,
tumour stage and grade, amount of residual disease, subtype,
smoking status, BMI, PAI, daily energy intake, and, where
appropriate, marital status. Tests for linear trend were based on
category median values. Finally, we conducted a sensitivity
analysis, restricting to women diagnosed with high-grade (grade
3) serous tumours in order to determine diet–mortality associa-
tions within this homogenous subgroup.
RESULTS
Clinical, socio-demographic, and lifestyle characteristics of the 811
women included in this analysis are presented in Table 1. A total of
547 (67%) women died during follow-up, 5-year survival was
59.9% and median survival was 59.6 months. Serous histological
subtype, later-stage disease, moderately or poorly differentiated
tumour, greater residual disease, tumour originating in the
peritoneum or fallopian tube, parity, lower educational attainment,
not having a current partner, and havingX1 comorbid conditions
were statistically significantly associated with worse survival in this
cohort in univariate analyses.
Table 2 presents the associations between diet exposures and
overall mortality. There was a trend for lower mortality with higher
fruit intake (P-trend¼ 0.04). Higher intake of green leafy
vegetables was inversely associated with mortality (HR¼ 0.75,
95% CI: 0.61, 0.93; HR¼ 0.79, 95% CI: 0.62, 0.99 for increasing
intake) although a linear trend was not evident (P-trend¼ 0.06). A
similar pattern was seen for fish intake (HR for X3 vs 0 servings
per day¼ 0.74, 95% CI: 0.57, 0.95, P-trend¼ 0.17). Cruciferous
vegetable and low-fat dairy intake did not meet the proportional
hazard assumption. In the lag analysis considering stages of follow-
up time, cruciferous vegetable and low-fat dairy intake was not
associated with mortality when restricting to p or 43 years’
follow-up time. Other food groups (grains, oily fish (tuna and
salmon), total meat and meat subgroups (poultry, red meat, and
processed meat), and low- and high-fat dairy) were not associated
with mortality. For beverages including black and green tea, and
coffee, we did not observe an association with mortality.
Table 3 presents the associations between nutrient intakes
(second, third, and fourth vs first quartile) and overall mortality.
Improved survival was evident for highest compared with lowest
quartile of fibre intake (HR¼ 0.69, 95% CI: 0.53, 0.90, P-
trend¼ 0.002) and worse survival with higher GI (HR¼ 1.28,
95% CI: 1.01, 1.65, P-trend¼ 0.03). Polyunsaturated to mono-
unsaturated fat ratio (PUFA:MUFA) was associated with lower
mortality for the highest compared with lowest quartile of intake
(HR¼ 0.76, 95% CI: 0.59, 0.98, P-trend¼ 0.06). There was a
suggestive trend for increasing risk of mortality with higher intakes
of saturated fat (P¼ 0.07). No association was observed between
total vitamin C, E, b-carotene, and retinol from diet plus
supplements, total fat, mono or polyunsaturated fat alone, or GL
and mortality.
Table 4 presents associations between dietary supplement use
and overall mortality. The interaction of vitamin C intake from
supplements with survival time was statistically significant. Above
median intake of vitamin C (180mg per day) from supplements
was positively associated with mortality during the first 5 years
after diagnosis (HR vs no use¼ 1.36, 95% CI: 1.04, 1.78) but was
not associated with mortality after 5 years. Among vitamin C
supplement users, the range of intake was up to 2039mg per day
(IQR: 74–500).
We analysed 34 diet–mortality associations; adjusting for
multiple comparisons would result in significant associations at a
false discovery rate set at 0.2 of o0.006 (0.2/(34/1)) for the
highest-ranked P-value. Thus, taking this into consideration, the
inverse association between fibre and mortality remained statisti-
cally significant for this agnostic analysis.
Similar patterns were seen in sensitivity analyses restricted to
women with high-grade serous tumours however the associations
tended to be slightly stronger. As a result the inverse associations
with total vegetable, oily fish, and green tea intake, and the positive
association with total fat intake reached statistical significance
(Supplementary Tables S2–S4). A significant inverse trend was also
seen for cruciferous vegetables and a significant positive trend for
coffee intake although none of the individual category estimates
reached statistical significance.
DISCUSSION
Our findings from a large, Australian population-based sample of
women diagnosed with invasive epithelial ovarian cancer support a
possible association between pre-diagnostic diet and survival after
diagnosis. Overall, we observed a survival advantage for higher
intakes of total and green leafy vegetables, fruit, fish, fibre intake,
and PUFA:MUFA ratio, while higher GI was associated with worse
survival. Higher vitamin C intake from supplements was inversely
associated with survival up to 5 years after diagnosis but not after 5
years. A significant dose–response relationship (for survival
advantage) was observed for both increasing fibre intake (better
survival) and GI (worse survival). After controlling for multiple
comparisons, the association with fibre remained statistically
significant. Our findings were independent of tumour character-
istics and, when we restricted to high-grade serous cases, the
associations remained and we also observed a trend for reduced
mortality risk with higher cruciferous vegetable and green tea
intakes. These findings expand on a limited area of research as, to
our knowledge, only five studies have been conducted on dietary
exposures and survival after ovarian cancer diagnosis (Nagle et al,
2003; Zhang et al, 2004; Sakauchi et al, 2007; Yang et al, 2008;
Dolecek et al, 2010; Thomson et al, 2014).
The World Cancer Research Fund Continuous Update Project
Report on diet and risk of ovarian cancer judged the evidence that
diet has a role as only limited/suggestive due to the scarcity and/or
inconsistency of findings to date (World Cancer Research Fund/
American Institute for Cancer Research, 2014). Nonetheless,
emerging evidence supports some associations between diet and
ovarian cancer survival. Findings from the Women’s Health
Initiative (N¼ 636 ovarian cancer cases) found significantly lower
all-cause mortality for women reporting higher pre-diagnosis diet
quality as measured by the Healthy Eating Index–2005, but no
significant associations with the individual dietary components
contributing to the dietary score (Thomson et al, 2014). It is
possible that overall pattern of food consumption that accounts for
correlated intakes and food/nutrient interactions is a more
important exposure in the context of ovarian cancer as opposed
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to the role of single foods or nutrients. A large-scale prospective
cohort study in Japan (N¼ 64 327 women) assessed baseline
frequency of intake of 32 food items and followed women for an
average of 13 years; 77 women died of ovarian cancer. Salted fish
and pickled Chinese cabbage were positively associated with
ovarian cancer mortality but no other dietary associations were
observed (Sakauchi et al, 2007). As survival was not the focus of
this cohort, it is unclear how these dietary exposures were
associated with ovarian cancer incidence and subsequent survival.
A longitudinal study of 341women enrolled in a United States (US)
case–control study between 1994 and 1998 found better survival
for women with higher intake of fruits plus vegetables, total
vegetables, and yellow and cruciferous vegetables pre-diagnosis
(Dolecek et al, 2010). They also observed poorer survival with
higher intakes of red and cured meats, and milk. Those findings
were generally supported by another Australian study of 609
women diagnosed between 1990 and 1993, where better survival
was observed with higher pre-diagnosis intakes of vegetables,
cruciferous vegetables, and vitamin E, whereas lactose, dairy
products, protein, red meat, and white meat were associated with
worse survival (Nagle et al, 2003).
Some of these associations for individual foods were not
observed in our current population; however, there are a number
of differences between the studies. Compared with the current
analysis, the US sample was slightly younger with earlier disease at
diagnosis. Dietary intake was reported for the 3- to 5-year period
before diagnosis as opposed to 12 months in this study, and the
previous Australian study (Nagle et al, 2003; Dolecek et al, 2010).
Similarly, participants in the first Australian study were younger
with earlier-stage disease (Nagle et al, 2003). However, when we
restricted analyses to participants agedo50 years, results were not
altered significantly with regards to these dietary components. As
cases in the current study were diagnosed 10 years after the first
Australian study, changes in food consumption patterns could
have influenced heterogeneity of exposure (Flood et al, 2010;
Arabshahi et al, 2011), although intakes appeared similar to those
in the previous study.
We observed an inverse association between green leafy
vegetables (spinach and lettuces) and mortality, and a trend for
reduced mortality risk with higher fruit intake. Spinach is rich in
beta-carotene, lutein/zeaxanthin, and other vitamins and minerals.
While two population-based case–control studies have reported
reduced risks of ovarian cancer for the highest compared with
lowest intakes of lutein/zeaxanthin (Bertone et al, 2001), two
prospective cohorts found no association between green leafy
vegetable intake and incident epithelial ovarian cancer (Larsson
et al, 2004; Schulz et al, 2005). A previous analysis reported an
inverse association between pre-diagnosis intake of fruit and
vegetables combined and ovarian cancer survival (Dolecek et al,
2010), but analyses of diet and survival after diagnosis of ovarian
cancer to date have grouped spinach/lettuce intake with total
vegetable intake (Nagle et al, 2003; Dolecek et al, 2010). In addition
to fibre, green leafy vegetables are also a good source of other
nutrients shown to be implicated in cancer aetiology, including
folate and flavonoids, although evidence for their roles in
ovarian cancer survival is sparse (Zhang et al, 2004; Dixon et al,
2014).
For total fish intake, we observed a protective association with
survival, but no dose–response relationship. In two Australian
case–control studies, higher fish intake was associated with lower
risk (Kolahdooz et al, 2010) but a meta-analysis of 15 case–control
and cohort studies found that total fish consumption was not
associated with ovarian cancer risk overall, although it was
protective in Australian/European but not in Asian/North Amer-
ican studies (Jiang et al, 2014). Mechanisms proposed to
explain the protective effect of fish intake include the rich source
of omega-3 fatty acids and their anti-apoptotic and anti-
Table 1. Clinical, socio-demographic, and lifestyle
characteristics and associations with all-cause mortality
among women diagnosed with invasive ovarian cancer
participating in the AOCS (n¼811)
Characteristics N (%)a Deceased (%) Univariate HR (95% CI)b
Age at diagnosis
o50 years 148 (18) 49 1.00 (ref)
50–59 years 269 (33) 64 1.47 (1.12, 1.94)
60–69 years 250 (31) 75 1.92 (1.46, 2.52)
X70 years 144 (18) 81 2.49 (1.86, 3.35)
Histological subtype
Serous 536 (66) 79 1.00 (ref)
Mucinous 30 (4) 33 0.27 (0.15, 0.51)
Endometrioid 88 (11) 31 0.25 (0.17, 0.37)
Clear cell 54 (7) 44 0.42 (0.28, 0.64)
Other 103 (13) 63 0.73 (0.56, 0.95)
Stage
I/II 234 (29) 30 1.00 (ref)
III/IV 571 (71) 82 4.93 (3.83, 6.34)
Grade
Well differentiated 76 (9) 41 1.00 (ref)
Moderately differentiated 156 (19) 69 2.27 (1.52, 3.39)
Poorly differentiated 530 (65) 72 2.46 (1.71, 3.56)
Missing 49 (6) 55 1.61 (0.96, 2.70)
Residual disease
No residual 328 (40) 42 1.00 (ref)
p1 cm 181 (22) 85 3.46 (2.75, 4.37)
41 cm 185 (23) 91 4.53 (3.60, 5.70)
Missing 117 (14) 74 2.36 (1.80, 3.08)
Ovarian cancer site
Ovary 703 (87) 66 1.00 (ref)
Peritoneum/fallopian tube 108 (13) 78 1.38 (1.09, 1.74)
Hormone therapy use
No 484 (60) 64 1.00 (ref)
Yes 320 (39) 73 1.14 (0.96, 1.35)
Parity
None 143 (18) 53 1.00 (ref)
1–2 pregnancies 343 (42) 66 1.41 (1.09, 1.83)
X3 pregnancies 323 (40) 75 1.69 (1.30, 2.19)
Body mass index (kgm2)
o18.5 (underweight) 40 (5) 70 1.07 (0.72, 1.58)
18.5–o25 (normal weight) 382 (47) 68 1.00 (ref)
25–o30 (overweight) 239 (29) 67 0.88 (0.73, 1.08)
X30 (obese) 141 (17) 66 0.92 (0.73, 1.17)
Physical activity index
Low 176 (22) 73 1.00 (ref)
Medium 295 (36) 66 0.83 (0.67, 1.03)
High 339 (42) 66 0.81 (0.65, 1.02)
Education
School only 440 (54) 74 1.00 (ref)
Trade or technical 257 (32) 61 0.74 (0.62, 0.90)
University 114 (14) 59 0.73 (0.56, 0.95)
Marital status
Current partner 591 (73) 66 1.00 (ref)
Ex-partner/never married 218 (27) 72 1.25 (1.04, 1.50)
Number of comorbidities
None 621 (77) 65 1.00 (ref)
X1 187 (23) 76 1.35 (1.11, 1.63)
Current smoker (1 year before diagnosis)
Never 488 (60) 69 1.00 (ref)
Former 209 (26) 63 0.86 (0.70, 1.05)
Current 114 (14) 68 1.00 (0.78, 1.29)
Vital status
Alive 264 (33)
Deceased 547 (67)
Abbreviations: AOCS¼Australian Ovarian Cancer Study; CI¼ confidence interval;
HR¼hazard ratio; ref¼ reference.
aPercentages may not sum to 100% due to rounding.
bCox proportional hazards regression.
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Table 2. Association between pre-diagnosis food and beverage intake and overall mortality among women diagnosed with
invasive ovarian cancer participating in the AOCS (n¼811)
Dietary variable N (%) Deaths, N (%) Age and energy-adjusted HR (95% CI) Multivariate HR (95% CI)a Multivariate P-trendb
Fruit (servings per day)
None or o2 206 (25) 141 (26) 1.00 (ref) 1.00 (ref) 0.04
2–o4 275 (34) 187 (34) 0.83 (0.66, 1.03) 0.91 (0.72, 1.16)
X4 330 (41) 219 (40) 0.78 (0.61, 0.99) 0.82 (0.63, 1.07)
Total vegetables (servings per day)
None or o3 213 (26) 143 (26) 1.00 (ref) 1.00 (ref) 0.48
3–o5 331 (41) 221 (40) 0.90 (0.72, 1.11) 0.95 (0.76, 1.18)
X5 267 (33) 183 (33) 0.93 (0.73, 1.19) 0.88 (0.68, 1.13)
Green leafy vegetables (servings per day)
None or o0.33 255 (31) 173 (32) 1.00 (ref) 1.00 (ref) 0.06
0.33–o0.67 311 (38) 210 (38) 0.92 (0.76, 1.13) 0.75 (0.61, 0.93)
X0.67 245 (30) 164 (30) 0.94 (0.76, 1.18) 0.79 (0.62, 0.99)
Cruciferous vegetables (servings per day)
None or o0.75 425 (52) 287 (52) 1.00 (ref) 1.00 (ref) 0.66c
0.75–o1.5 257 (32) 169 (31) 0.87 (0.72, 1.06) 0.90 (0.74, 1.10)
X1.5 129 (16) 91 (17) 1.03 (0.81, 1.31) 0.99 (0.77, 1.29)
Red/yellow vegetables (servings per day)
None or o1 219 (27) 145 (27) 1.00 (ref) 1.00 (ref) 0.40d
1–o2 407 (50) 279 (51) 0.95 (0.78, 1.17) 0.92 (0.74, 1.14)
X2 185 (23) 123 (22) 0.90 (0.69, 1.18) 0.91 (0.69, 1.20)
Grains (servings per day)
None or o2 227 (28) 140 (26) 1.00 (ref) 1.00 (ref) 0.75
2–o4 367 (45) 253 (46) 1.23 (0.99, 1.53) 1.12 (0.89, 1.40)
X4 217 (27) 154 (28) 1.18 (0.91, 1.52) 1.11 (0.85, 1.45)
Total meat (servings per day)
None or o1 268 (33) 172 (31) 1.00 (ref) 1.00 (ref) 0.43
1–o2 424 (52) 298 (54) 1.22 (1.00, 1.49) 1.14 (0.95, 1.43)
X2 119 (15) 77 (14) 1.18 (0.87, 1.60) 0.98 (0.71, 1.35)
Poultry (servings per week)
None or o1 280 (35) 192 (35) 1.00 (ref) 1.00 (ref) 0.82
1–o2 150 (19) 103 (19) 1.05 (0.82, 1.33) 1.03 (0.80, 1.32)
X2 380 (47) 251 (46) 1.02 (0.84, 1.24) 0.98 (0.80, 1.20)
Processed meat (servings per week)
None or o1 314 (39) 211 (39) 1.00 (ref) 1.00 (ref) 0.81
1–o2 221 (27) 155 (28) 1.13 (0.92, 1.39) 1.25 (1.00, 1.55)
X2 276 (34) 181 (33) 1.08 (0.88, 1.33) 1.08 (0.86, 1.35)
Red meat (servings per week)
None or o2 126 (16) 77 (14) 1.00 (ref) 1.00 (ref) 0.44
2–o4 220 (27) 151 (28) 1.22 (0.92, 1.61) 1.28 (0.96, 1.71)
4–o6 214 (26) 143 (26) 1.20 (0.91, 1.60) 1.18 (0.88, 1.58)
X6 251 (31) 176 (32) 1.32 (0.98, 1.76) 1.21 (0.89, 1.64)
Total fish (servings per week)
None or o1 183 (23) 132 (24) 1.00 (ref) 1.00 (ref) 0.17d
1–o2 229 (28) 154 (28) 0.86 (0.68, 1.08) 0.70 (0.55, 0.89)
2–o3 142 (18) 98 (18) 0.95 (0.73, 1.24) 0.76 (0.58, 1.00)
X3 257 (32) 163 (30) 0.85 (0.67, 1.08) 0.74 (0.57, 0.95)
Oily fish (servings per week)
None 103 (13) 76 (14) 1.00 (ref) 1.00 (ref) 0.71
o1 402 (50) 270 (49) 0.77 (0.60, 1.00) 0.61 (0.47, 0.80)
o1–2 156 (19) 106 (19) 0.81 (0.60, 1.08) 0.61 (0.45, 0.84)
X2 150 (19) 95 (17) 0.80 (0.59, 1.09) 0.80 (0.58, 1.11)
Low-fat dairy (servings per day)
None 141 (17) 102 (19) 1.00 (ref) 1.00 (ref) 0.68c
40–1 331 (41) 222 (41) 0.88 (0.69, 1.11) 0.81 (0.64, 1.04)
41–2 199 (25) 128 (23) 0.79 (0.61, 1.02) 0.79 (0.59, 1.04)
42 139 (17) 94 (17) 0.90 (0.67, 1.19) 0.98 (0.73, 1.33)
High-fat dairy (servings per day)
None or r1 361 (45) 238 (44) 1.00 (ref) 1.00 (ref) 0.32
41–2 283 (35) 195 (36) 1.00 (0.82, 1.22) 1.15 (0.94, 1.42)
42 167 (21) 114 (21) 1.12 (0.88, 1.42) 1.11 (0.87, 1.42)
Coffee (250ml mugs per day)
None 156 (19) 105 (19) 1.00 (ref) 1.00 (ref) 0.86d
p1 303 (37) 204 (37) 0.89 (0.70, 1.13) 0.86 (0.67, 1.10)
41–p2 90 (11) 62 (11) 1.13 (0.83, 1.55) 1.14 (0.82, 1.57)
42–p3 183 (23) 130 (24) 1.08 (0.84, 1.40) 1.03 (0.79, 1.35)
43 79 (10) 46 (8) 0.79 (0.56, 1.12) 0.83 (0.58, 1.19)
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inflammatory properties (Fernandez et al, 1999; Sharma et al,
2005). Fish has not previously been analysed independently of
other white meats in relation to ovarian cancer survival (Nagle
et al, 2003; Dolecek et al, 2010).
We observed a beneficial effect of dietary fibre, which lowers
circulating oestrogens by inhibiting bile reabsorption and increas-
ing faecal excretion (Ferrari et al, 2013), on survival. In the
previous Australian analysis, fibre was not associated with ovarian
cancer survival (Nagle et al, 2003), although the median of the
highest-intake category was lower than the current analysis (35 vs
43 g per day). We found a similarly null association for fibre intake
of 35 g per day, suggesting a protective effect only for particularly
high levels of fibre intake. To date, no other studies have explored
this association. Findings for the association between fibre intake
and ovarian cancer risk have been mixed (Silvera et al, 2007a;
Hedelin et al, 2011), although fibre intake has been associated with
lower breast cancer mortality (Belle et al, 2011; Buck et al, 2011). A
high-fibre, low-fat dietary intervention was shown to reduce
bioavailable oestrogen among women diagnosed with breast
cancer, a plausible mechanism in the context of improving ovarian
cancer survival (Rock et al, 2004). Other potential mechanisms for
fibre’s inverse association with mortality include its influence on
inflammation (Ma et al, 2008; Villasenor et al, 2011), and
metabolic regulation including effects on GI (Lattimer and Haub,
2010).
We found suggestive evidence for a trend towards poorer
survival with increasing saturated fat intake, which has not been
observed in prior studies (Nagle et al, 2003; Dolecek et al, 2010).
High dietary fat intake has been proposed to increase circulating
progesterone and oestrogens, promoting tumour development
(Pyragius et al, 2013). Previous investigations highlight the
inconsistency of this association (Genkinger et al, 2006; Blank
et al, 2012).
The ratio of PUFA:MUFA was inversely associated with
mortality. PUFA, largely found in nuts, seeds, fish, and leafy green
vegetables, includes both omega-3 (n-3) and omega-6 (n-6)
subtypes; avocado, canola, and olive oils are good sources of
MUFA. A large population-based case–control study (n¼ 1872
cases and 1978 controls) found a lower risk of epithelial ovarian
cancer for the highest compared with lowest intakes of overall
PUFA, n-3 and n-6 PUFA, but no association with MUFA (Merritt
et al, 2014). The ratio of PUFA:MUFA was not associated with risk
for developing ovarian cancer in a second study (Ibiebele et al,
2012). Unsaturated fatty acids have a role in cell membrane
integrity and can affect cell function through eicosanoid synthesis,
gene expression regulation, and effects on apoptosis and cell
proliferation (Abel et al, 2014). Previous studies have shown that
n-3 FA inhibit ovarian cancer cell proliferation (Sharma et al, 2005;
Sharma et al, 2009), but the importance of n-6:n-3 and
PUFA:MUFA in the context of carcinogenesis remains unclear
(Abel et al, 2014). Prior studies of diet and ovarian cancer survival
have not assessed unsaturated fatty acid ratio (Nagle et al, 2003;
Zhang et al, 2004; Sakauchi et al, 2007; Yang et al, 2008; Dolecek
et al, 2010).
GI showed a positive linear relationship with mortality. Previous
case–control and prospective cohort studies have reported mixed
findings for the association between GI and ovarian cancer risk
(Augustin et al, 2003; Silvera et al, 2007b; George et al, 2009; Nagle
et al, 2011). The GI quantitatively assesses the effect of food on
post-consumption blood glucose levels and is purported to
influence carcinogenesis by increasing circulating insulin-like
growth factors and oestrogens, and promoting tumour progression
through insulin-related cell signalling (George et al, 2009). Studies
on ovarian cancer survival are lacking.
Vitamin C supplement intake was positively associated with
mortality for the earlier period of follow-up (up to 5 years) but we
found no association with vitamin C from diet alone. Previous
investigations on ovarian cancer survival have not reported on
supplemental vitamin C and findings for the association with
ovarian cancer risk have been mixed (Fleischauer et al, 2001;
Chang et al, 2008; Crane et al, 2014; Koushik et al, 2015). A null
association between vitamin C from food and ovarian cancer risk
but a harmful effect for vitamin C supplement use has also been
reported (Gifkins et al, 2012). Findings from the WHI among
vitamin C replete postmenopausal women also showed that
women who went on to develop ovarian cancer had significantly
higher vitamin C supplement intake than controls. Proposed
mechanisms included vitamin C pro-oxidant activity and enhanced
iron absorption with iron-associated oxidative stress and effects on
malignant transformation (Thomson et al, 2008). Future studies
powered to explore dietary supplement intake and ovarian cancer
survival with characterisation of dose, formulation, and duration
are warranted.
Our study has several strengths, including its large sample
size, long duration and complete follow-up, population-based case
selection and detailed collection of information on tumour
characteristics, and lifestyle factors, allowing adjustment for
known prognostic factors. There was comprehensive measurement
of food, nutrient, and dietary supplement exposures. Some
limitations should be addressed. Diet was measured pre-diagnosis
and may not reflect intake after diagnosis. Nevertheless, although
some women may change their diet after cancer diagnosis, overall,
pre-diagnosis diet is likely to be correlated with post-diagnosis diet.
Studies of breast cancer survivors suggest dietary changes after
Table 2. ( Continued )
Dietary variable N (%) Deaths, N (%) Age and energy-adjusted HR (95% CI) Multivariate HR (95% CI)a Multivariate P-trendb
Black tea (250ml mugs per day)
None 135 (17) 91 (17) 1.00 (ref) 1.00 (ref) 0.73d
o1 168 (21) 96 (18) 0.78 (0.58, 1.04) 0.78 (0.59, 1.06)
1–o2 113 (14) 81 (15) 1.13 (0.84, 1.53) 0.94 (0.69, 1.29)
2–o3 274 (34) 195 (36) 1.00 (0.78, 1.29) 0.97 (0.74, 1.25)
X3 121 (15) 84 (15) 0.89 (0.66, 1.21) 0.78 (0.59, 1.06)
Green tea (250ml mugs per day)
Non-drinker 545 (67) 372 (68) 1.00 (ref) 1.00 (ref) 0.28
o1 194 (24) 128 (23) 0.96 (0.78, 1.17) 0.92 (0.75, 1.13)
X1 72 (9) 47 (9) 0.90 (0.66, 1.21) 0.83 (0.60, 1.15)
Abbreviations: AOCS¼Australian Ovarian Cancer Study; CI¼ confidence interval; HR¼ hazard ratio; ref¼ reference.
aCox proportional hazards regression, adjusted for age at diagnosis, International Federation of Gynaecology and Obstetrics (FIGO) stage, amount of residual disease, grade, tumour subtype,
smoking status, body mass index, physical activity index, marital status, and daily caloric intake.
bP-value for linear trend calculated from category median values.
cProportional hazards assumption not met; time–variable interaction statistically significant in multivariate model. Original hazard ratio (95% CI) without time–variable interaction included in the
model is presented.
dNot adjusted for marital status.
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Table 3. Association between nutrient intake from foods and supplements pre-diagnosis and overall mortality among women
diagnosed with invasive ovarian cancer participating in the AOCS (n¼811)
Quartilea
Nutrient 1 2 3 4 P-trendb
Fibre (g per day)
Deaths, N (% of total deaths) 129 (24) 143 (26) 144 (26) 131 (24) 0.002
Median 23 30 35 43
Age-/E-adjusted HR (95% CI) 1.00 (ref) 1.06 (0.83, 1.35) 0.95 (0.75, 1.21) 0.86 (0.67, 1.10)
Multivariate HR (95% CI) 1.00 (ref) 1.03 (0.80, 1.32) 0.89 (0.69, 1.14) 0.69 (0.53, 0.90)
Vitamin C (diet only; mg per day)
Deaths, N (% of total deaths) 139 (25) 136 (25) 135 (25) 137 (25) 0.53c
Median 112 158 200 276
Age-/E-adjusted HR (95% CI) 1.00 (ref) 0.92 (0.73, 1.16) 0.91 (0.72, 1.16) 0.88 (0.69, 1.11)
Multivariate HR (95% CI) 1.00 (ref) 1.01 (0.79, 1.30) 1.06 (0.82, 1.36) 0.93 (0.72, 1.19)
Vitamin C (diet and supplements; mg per day)
Deaths, N (% of total deaths) 139 (25) 144 (26) 139 (25) 125 (23) 0.82
Median 124 183 257 532
Age-/E-adjusted HR (95% CI) 1.00 (ref) 1.03 (0.82, 1.31) 0.97 (0.77, 1.23) 0.91 (0.71, 1.16)
Multivariate HR (95% CI) 1.00 (ref) 1.18 (0.93, 1.50) 1.11 (0.87, 1.42) 1.04 (0.81, 1.35)
Vitamin E (diet and supplements; mg per day)
Deaths, N (% of total deaths) 138 (25) 144 (26) 133 (24) 132 (24) 0.23
Median 6 8 10 40
Age-/E-adjusted HR (95% CI) 1.00 (ref) 0.99 (0.78, 1.25) 0.88 (0.69, 1.11) 0.98 (0.77, 1.25)
Multivariate HR (95% CI) 1.00 (ref) 0.94 (0.74, 1.20) 0.85 (0.66, 1.09) 1.07 (0.83, 1.37)
Beta-carotene (diet and supplements; lg per day)
Deaths, N (% of total deaths) 135 (25) 146 (27) 134 (25) 132 (24) 0.44
Median 2909 4757 6310 9183
Age-/E-adjusted HR (95% CI) 1.00 (ref) 0.97 (0.77, 1.23) 0.88 (0.69, 1.11) 0.85 (0.67, 1.08)
Multivariate HR (95% CI) 1.00 (ref) 0.93 (0.73, 1.19) 1.05 (0.82, 1.35) 0.89 (0.69, 1.14)
Retinol (diet and supplements; lg per day)
Deaths, N (% of total deaths) 131 (24) 147 (27) 135 (25) 134 (25) 0.57
Median 183 290 526 1433
Age-/E-adjusted HR (95% CI) 1.00 (ref) 1.16 (0.92, 1.47) 0.96 (0.75, 1.22) 0.93 (0.73, 1.19)
Multivariate HR (95% CI) 1.00 (ref) 1.27 (1.00, 1.63) 1.10 (0.85, 1.41) 1.05 (0.81, 1.34)
Total fat (g per day)
Deaths, N (% of total deaths) 137 (25) 137 (25) 138 (25) 135 (25) 0.27c
Median 57 68 76 86
Age-/E-adjusted HR (95% CI) 1.00 (ref) 1.07 (0.84, 1.35) 1.04 (0.82, 1.32) 1.12 (0.88, 1.42)
Multivariate HR (95% CI) 1.00 (ref) 1.28 (1.00, 1.64) 1.12 (0.87, 1.42) 1.19 (0.92, 1.53)
Monounsaturated fat (g per day)
Deaths, N (% of total deaths) 131 (24) 143 (26) 141 (26) 132 (24) 0.55
Median 20 24 27 32
Age-/E-adjusted HR (95% CI) 1.00 (ref) 1.28 (1.01, 1.62) 1.23 (0.97, 1.56) 1.10 (0.87, 1.40)
Multivariate HR (95% CI) 1.00 (ref) 1.31 (1.03, 1.67) 1.26 (0.98, 1.61) 1.09 (0.85, 1.41)
Polyunsaturated fat (g per day)
Deaths, N (% of total deaths) 132 (24) 143 (26) 146 (27) 126 (23) 0.46
Median 9 11 13 16
Age-/E-adjusted HR (95% CI) 1.00 (ref) 1.14 (0.90, 1.45) 1.15 (0.91, 1.45) 0.93 (0.73, 1.19)
Multivariate HR (95% CI) 1.00 (ref) 0.94 (0.74, 1.20) 1.01 (0.79, 1.30) 0.89 (0.69, 1.15)
Saturated fat (g per day)
Deaths, N (% of total deaths) 134 (25) 136 (25) 138 (25) 139 (25) 0.07c
Median 19 25 29 35
Age-/E-adjusted HR (95% CI) 1.00 (ref) 1.03 (0.81, 1.31) 1.11 (0.88, 1.41) 1.17 (0.92, 1.48)
Multivariate HR (95% CI) 1.00 (ref) 1.12 (0.87, 1.43) 1.30 (1.02, 1.67) 1.23 (0.96, 1.58)
PUFA:MUFA
Deaths, N (% of total deaths) 136 (25) 136 (25) 144 (26) 131 (24) 0.06
Median 0.36 0.43 0.49 0.59
Age-/E-adjusted HR (95% CI) 1.00 (ref) 0.92 (0.73, 1.17) 0.94 (0.74, 1.19) 0.82 (0.64, 1.04)
Multivariate HR (95% CI) 1.00 (ref) 0.82 (0.64, 1.05) 0.85 (0.66, 1.08) 0.76 (0.59, 0.98)
Glycaemic index
Deaths, N (% of total deaths) 128 (23) 133 (24) 136 (25) 150 (27) 0.03c
Median 45 48.5 51.4 55.1
Age-/E-adjusted HR (95% CI) 1.00 (ref) 1.03 (0.81, 1.31) 1.11 (0.87, 1.41) 1.30 (1.03, 1.65)
Multivariate HR (95% CI) 1.00 (ref) 1.07 (0.83, 1.37) 1.13 (0.88, 1.45) 1.28 (1.01, 1.65)
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diagnosis are modest (Wayne et al, 2004), and limited post-
diagnosis dietary data available for 289 women in our cohort
showed moderate correlations for fruit, vegetables, and meat
(intraclass correlations 0.46, 0.32, and 0.42, respectively). Further-
more, we restricted the current analysis to women who reported no
change in their diet for the 6–12 months before diagnosis. There is
the potential for selection bias if the association between diet
and survival differs by characteristics of participants compared
with non-participants, given that enrolment was limited to
those well enough to complete dietary assessment. However, this
cohort included women who diagnosed primarily with later-
stage disease, reflecting the general population of ovarian
cancer survivors. Information or recall bias is a possible limitation
as diagnosis of late-stage disease with reduced wellbeing may
have influenced dietary recall, although our results were adjusted
for stage and grade of disease, and we observed similar
associations by disease stage. Any measurement error, inherent
in self-report measures for dietary assessment, is likely to have
attenuated real associations and thus cannot explain the associa-
tions seen. Given the observational design, it is possible that
observed associations are due to confounding by unknown or
unmeasured confounding factors although we adjusted for
the key factors known to influence ovarian cancer survival. Results
may be due to chance; after controlling for multiple comparisons,
only fibre remained statistically significantly inversely associated
with mortality.
In summary, in one of few dietary analyses within a large,
observational study of women diagnosed with invasive ovarian
cancer, we observed improved survival with higher intakes of
dietary fibre. There was a suggestion of improved survival with
higher consumption of green leafy vegetables, fish, and PUFA:-
MUFA ratio, and poorer survival with higher GI that require
replication in future large-scale prospective studies. These
observations that healthy components of a pre-diagnosis diet are
associated with ovarian cancer survival raise the possibility that
healthful dietary choices after diagnosis may improve ovarian
cancer survival. The role of diet in ovarian cancer survival would
be further clarified by analyses of post-diagnosis diet, evidence for
which is currently being gathered in a randomised, controlled
(Thomson et al, 2016).
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Quartilea
Nutrient 1 2 3 4 P-trendb
Glycaemic load
Deaths, N (% of total deaths) 127 (23) 134 (25) 147 (27) 139 (25) 0.28c
Median 93 111 125 142
Age-/E-adjusted HR (95% CI) 1.00 (ref) 0.99 (0.78, 1.26) 1.23 (0.97, 1.56) 1.08 (0.85, 1.38)
Multivariate HR (95% CI) 1.00 (ref) 1.07 (0.83, 1.38) 1.22 (0.95, 1.57) 1.12 (0.87, 1.44)
Abbreviations: AOCS¼Australian Ovarian Cancer Study; CI¼ confidence interval; E¼energy; HR¼hazard ratio; MUFA¼monounsaturated fat; PUFA¼polyunsaturated fat; ref¼ reference.
aCox proportional hazards regression, adjusted for age at diagnosis, International Federation of Gynaecology and Obstetrics (FIGO) stage, amount of residual disease, grade, tumour subtype,
smoking status, body mass index, physical activity index, and daily caloric intake.
bP-value for linear trend calculated from category median values.
cAdditionally adjusted for marital status.
Table 4. Association between dietary supplement intake pre-diagnosis and overall mortality among women diagnosed with
invasive ovarian cancer participating in the AOCS (n¼811)
Supplement N (%) Deaths, N (%) Age and energy-adjusted HR (95% CI) Multivariate HR (95% CI)a P-value
Takes multivitamin supplements
No 618 (76) 421 (77) 1.00 (ref) 1.00 (ref) 0.16
Yes 192 (24) 125 (23) 1.14 (1.93, 1.40) 1.16 (0.94, 1.43)
Takes vitamin B supplements
No 697 (86) 471 (89) 1.00 (ref) 1.00 (ref) 0.30b
Yes 88 (11) 60 (11) 1.00 (0.76, 1.33) 1.16 (0.88, 1.53)
Total vitamin C from supplementsc
None 542 (67) 377 (69) 1.00 (ref) 1.00 (ref) 0.74d
p180mg per day 131 (16) 84 (10) 1.11 (0.87, 1.41) 1.20 (0.93, 1.54)
4180mg per day 138 (17) 86 (16) 0.96 (0.76, 1.21) 1.05 (0.82, 1.35)
Total vitamin E from supplementsc
None 618 (76) 421 (77) 1.00 (ref) 1.00 (ref) 0.14
p30mg per day 91 (11) 56 (10) 1.06 (0.80, 1.41) 1.12 (0.84, 1.50)
430mg per day 102 (13) 70 (13) 1.11 (0.86, 1.43) 1.22 (0.94, 1.59)
Abbreviations: AOCS¼Australian Ovarian Cancer Study; CI¼ confidence interval; HR¼ hazard ratio; ref¼ reference.
aCox proportional hazards regression, adjusted for age at diagnosis, International Federation of Gynaecology and Obstetrics (FIGO) stage, amount of residual disease, grade, tumour subtype,
smoking status, body mass index, physical activity index, and daily caloric intake.
bAdditionally adjusted for marital status.
cDose categories are based on nutrients present in individual supplements plus nutrients from multivitamin supplements.
dProportional hazards assumption not met; time–variable interaction statistically significant in multivariate model. Original hazard ratio (95% CI) without time–variable interaction included in the
model is presented.
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